PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
AGL vs. AORT
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between AGL and AORT is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

AGL vs. AORT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in agilon health, inc. (AGL) and Artivion, Inc. (AORT). The values are adjusted to include any dividend payments, if applicable.

-100.00%-80.00%-60.00%-40.00%-20.00%0.00%20.00%40.00%OctoberNovemberDecember2025FebruaryMarch
-87.10%
3.40%
AGL
AORT

Key characteristics

Sharpe Ratio

AGL:

-0.35

AORT:

0.57

Sortino Ratio

AGL:

0.08

AORT:

1.05

Omega Ratio

AGL:

1.01

AORT:

1.13

Calmar Ratio

AGL:

-0.34

AORT:

0.33

Martin Ratio

AGL:

-0.71

AORT:

2.27

Ulcer Index

AGL:

46.52%

AORT:

7.77%

Daily Std Dev

AGL:

94.13%

AORT:

31.02%

Max Drawdown

AGL:

-96.37%

AORT:

-95.72%

Current Drawdown

AGL:

-90.75%

AORT:

-44.45%

Fundamentals

Market Cap

AGL:

$1.65B

AORT:

$984.76M

EPS

AGL:

-$0.61

AORT:

-$0.32

Total Revenue (TTM)

AGL:

$6.06B

AORT:

$388.54M

Gross Profit (TTM)

AGL:

-$6.91M

AORT:

$240.96M

EBITDA (TTM)

AGL:

-$230.59M

AORT:

$40.65M

Returns By Period

In the year-to-date period, AGL achieves a 110.53% return, which is significantly higher than AORT's -18.08% return.


AGL

YTD

110.53%

1M

16.62%

6M

20.85%

1Y

-24.53%

5Y*

N/A

10Y*

N/A

AORT

YTD

-18.08%

1M

-23.11%

6M

-5.37%

1Y

17.22%

5Y*

1.46%

10Y*

8.42%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

AGL vs. AORT — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AGL
The Risk-Adjusted Performance Rank of AGL is 3535
Overall Rank
The Sharpe Ratio Rank of AGL is 3232
Sharpe Ratio Rank
The Sortino Ratio Rank of AGL is 3939
Sortino Ratio Rank
The Omega Ratio Rank of AGL is 3939
Omega Ratio Rank
The Calmar Ratio Rank of AGL is 3030
Calmar Ratio Rank
The Martin Ratio Rank of AGL is 3636
Martin Ratio Rank

AORT
The Risk-Adjusted Performance Rank of AORT is 6969
Overall Rank
The Sharpe Ratio Rank of AORT is 7272
Sharpe Ratio Rank
The Sortino Ratio Rank of AORT is 6666
Sortino Ratio Rank
The Omega Ratio Rank of AORT is 6464
Omega Ratio Rank
The Calmar Ratio Rank of AORT is 6767
Calmar Ratio Rank
The Martin Ratio Rank of AORT is 7373
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

AGL vs. AORT - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for agilon health, inc. (AGL) and Artivion, Inc. (AORT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for AGL, currently valued at -0.35, compared to the broader market-3.00-2.00-1.000.001.002.003.00-0.350.57
The chart of Sortino ratio for AGL, currently valued at 0.08, compared to the broader market-4.00-2.000.002.004.000.081.05
The chart of Omega ratio for AGL, currently valued at 1.01, compared to the broader market0.501.001.502.001.011.13
The chart of Calmar ratio for AGL, currently valued at -0.34, compared to the broader market0.001.002.003.004.005.00-0.340.45
The chart of Martin ratio for AGL, currently valued at -0.71, compared to the broader market-10.000.0010.0020.00-0.712.27
AGL
AORT

The current AGL Sharpe Ratio is -0.35, which is lower than the AORT Sharpe Ratio of 0.57. The chart below compares the historical Sharpe Ratios of AGL and AORT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00OctoberNovemberDecember2025FebruaryMarch
-0.35
0.57
AGL
AORT

Dividends

AGL vs. AORT - Dividend Comparison

Neither AGL nor AORT has paid dividends to shareholders.


TTM20242023202220212020201920182017201620152014
AGL
agilon health, inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
AORT
Artivion, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%1.11%1.04%

Drawdowns

AGL vs. AORT - Drawdown Comparison

The maximum AGL drawdown since its inception was -96.37%, roughly equal to the maximum AORT drawdown of -95.72%. Use the drawdown chart below to compare losses from any high point for AGL and AORT. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%OctoberNovemberDecember2025FebruaryMarch
-90.75%
-26.97%
AGL
AORT

Volatility

AGL vs. AORT - Volatility Comparison

agilon health, inc. (AGL) has a higher volatility of 20.72% compared to Artivion, Inc. (AORT) at 9.25%. This indicates that AGL's price experiences larger fluctuations and is considered to be riskier than AORT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%20.00%30.00%40.00%50.00%60.00%OctoberNovemberDecember2025FebruaryMarch
20.72%
9.25%
AGL
AORT

Financials

AGL vs. AORT - Financials Comparison

This section allows you to compare key financial metrics between agilon health, inc. and Artivion, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab